Skip to content

Efficacy and safety of ciprofol for the induction of general anesthesia in elderly patients: a randomized, double-blind, propofol-controlled clinical trial

Efficacy and safety of ciprofol for the induction of general anesthesia in elderly patients: a randomized, double-blind, propofol-controlled clinical trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063623
Enrollment
Unknown
Registered
2022-09-13
Start date
2022-09-13
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general anesthesia

Interventions

CIP1:ciprofol 0.25mg/kg
CIP2:ciprofol 0.3mg/kg
CIP3:ciprofol 0.35mg/kg
PROP:propofol1.5mg/kg

Sponsors

General Hospital of Northern Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: a) Age = 65 years old, regardless of gender; b) Patients scheduled for elective endotracheal intubation under general anesthesia; c) ASA grade ? ~ ?; d) BMI 18-30kg/m2; e) Voluntary signing of Informed Consent Form.

Exclusion criteria

Exclusion criteria: a) Known hypersensitivity to the active ingredient (s) or excipient (s) of cyclopofol or propofol injection; b) Difficult airway patients, patients with modified Mallampati classification ?; c) Pregnant or lactating patients; Patients with planned pregnancy within 1 month after operation; d) Severe cardiovascular system, respiratory system, nervous system, liver and kidney diseases before operation; Patients with blood and metabolic diseases; e) Patients with severe disturbance of consciousness or mental system diseases (schizophrenia, mania, bipolar disorder, mental disorder, etc.) And cognitive dysfunction; f) Long-term smokers, drinkers and drug abusers; Patients with a history of sedative/anesthetic use within 1 month; g) Patients with significantly abnormal preoperative physical or laboratory findings.

Design outcomes

Primary

MeasureTime frame
success rate of induction in general anesthesia;The maximum decrease in systolic blood pressure;

Secondary

MeasureTime frame
time of successful induction of general anesthesia;Time of disappearance of eyelash reflex;change of BIS value;

Countries

China

Contacts

Public ContactDiao Yugang
Diao72@163.com15309881160

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026